论文部分内容阅读
以批发业务为主的嘉事堂,毛利率被进一步摊薄;第一医药推进“强店战略”以及药妆店、网上药店的建设;海王星辰继续扩充非药品类;一心堂则以上市为起点,继续扩张。嘉事堂(002462)、第一医药(600833)、海王星辰的2011年度报告以及云南鸿翔一心堂的招股说明书新近出炉,显示了四类包含药品零售业务上市企业的年度表现。嘉事堂素来重批发轻零售;第一医药零售与批发并重;海王星辰属纯零售业务;一心堂为准上市公司。基于企业定位的不同,各自零售业务的表现必然有所区别。
The gross margin was further diluted due to the wholesale business-based Jia-chih-pao; the first medicine promotion and the strategy of “strong store” and the construction of drugstore and online pharmacies; Nepstar continued to expand non-drug categories; Start, continue to expand. The recent announcement by Chittagong (002462), No. 1 Medicine (600833), Neptune’s 2011 annual report and Yunnan Hongxiang Yixintang’s prospectus shows the annual performance of the four categories of companies listed in the pharmaceutical retail business. Chiayi Hall has always been to wholesale and retail light; the first pharmaceutical retail and wholesale both; Nepstar is a pure retail business; Based on the different business positioning, the performance of their respective retail business must be different.